TheProfitWatch

MBRX - Moleculin Biotech, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.42 0.01 (3.56%) --- --- 0.0 (-0.81%) 0.01 (1.37%) 0.01 (2.26%) 0.01 (2.92%) 0.0 (-1.01%)

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.49
Diluted EPS:
Basic P/E:
-0.8776
Diluted P/E:
RSI(14) 1m:
43.21
VWAP:
0.43
RVol:

Events

Period Kind Movement Occurred At

Related News